Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected myocardial ischemia

被引:34
作者
Lippi, Giuseppe [1 ]
Filippozzi, Luca [2 ]
Montagnana, Martina [1 ]
Salvagno, Gian Luca [1 ]
Guidi, Gian Cesare [1 ]
机构
[1] Univ Verona, Dipartimento Sci Morfol Biomed, Osped Policlin GB Rossi, Sez Chim Clin, I-37134 Verona, Italy
[2] Azienda Osped Verona, Unit Operat Pronto Soccorso, Verona, Italy
关键词
acute coronary syndrome; D-dimer; myocardial infarction; myocardial ischemia; troponin;
D O I
10.1007/s11239-007-0060-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The accurate identification of patients with acute myocardial infarction ( AMI) remains one of the most difficult challenges facing emergency physicians. The introduction of early and reliable biomarkers of AMI should hence be acknowledged, since they would increase the efficiency of the diagnostic process. Methods A total of 2,276 consecutive patients referred to the emergency department for clinical symptoms suggestive for AMI underwent cardiac troponin T (cTnT) and D-dimer testing between January and December 2006. Patients sample were eligible for inclusion in this investigation if they had been collected prior to medication or intervention and 12-24 h after the time of patient's arrival to the emergency department, when the diagnostic efficiency of cTnT is the highest. cTnT was assayed on the Elecsys 2010 and test results were stratified according to the decisional threshold corresponding to the lowest TnT concentration associated with a 10% total imprecision in the assay (> 0.03 mu g/l). Plasma D-dimer was measured employing Vidas DD. Results The results of 741 patient's samples fulfilled the above criteria and were included in the study, 252 (34%) of whom had cTnT values > 0.03 mu g/l. The D-dimer value distribution ( median and 95% C.I.) was significantly different in patients with cTnT values > 0.03 mu g/l than in those with cTnT values < 0.03 mu g/l (2,227 mu g/l, 431-10,000 mu g/l versus 1,039 mu g/l, 143-6,338 mu g/l; P < 0.001). The area under the receiver operating characteristic ( ROC) curve, was 0.734 (95% confidence interval: 0.715-0.753; P < 0.001). At the 500 mu g/l diagnostic threshold estimated by the ROC curve analysis, corresponding to the cut- off for the diagnosis of VTE, sensitivity and specificity of Vidas D-dimer were 95% and 27%, respectively. The positive and negative predictive values were estimated as 92% and 41%, respectively. In linear regression analysis, no significant association (r = 0.090; P = 0.077) was observed between D-dimer and cTnT in patients with cTnT levels exceeding the decisional threshold of the assay. Conclusions Results of the present investigation on patients with AMI established by accepted diagnostic criteria (cTnT values above the decisional threshold of the assay associated with suggestive clinical symptoms), testify that D-dimer testing would not add clinically meaningful information to the sole determination of the cardiospecific troponins 12 - 24 h after patient's admission at the emergency department, when the cumulative data indicate that the diagnostic efficiency of cTnT is the highest.
引用
收藏
页码:247 / 250
页数:4
相关论文
共 20 条
[1]   INCREASED HEPARIN-RELEASABLE PLATELET FACTOR-4 AND D-DIMER IN PATIENTS ONE-MONTH AFTER THE ONSET OF ACUTE MYOCARDIAL-INFARCTION - PERSISTENT ACTIVATION OF PLATELETS AND THE COAGULATION FIBRINOLYTIC SYSTEM [J].
ABE, S ;
MARUYAMA, I ;
ARIMA, S ;
YAMAGUCHI, H ;
OKINO, H ;
HAMASAKI, S ;
YAMASHITA, T ;
NOMOTO, K ;
TAHARA, M ;
ATSUCHI, Y ;
NAKAO, S ;
TANAKA, H .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1994, 47 (01) :S7-S12
[2]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[3]   Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome [J].
Apple, FS ;
Wu, AHB ;
Mair, J ;
Ravkilde, J ;
Panteghini, M ;
Tate, J ;
Pagani, F ;
Christenson, RH ;
Mockel, M ;
Danne, O ;
Jaffe, AS .
CLINICAL CHEMISTRY, 2005, 51 (05) :810-824
[4]   D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain [J].
Bayes-Genis, A ;
Mateo, J ;
Santaló, M ;
Oliver, A ;
Guindo, J ;
Badimon, L ;
Martínez-Rubio, A ;
Fontcuberta, J ;
Schwartz, RS ;
de Luna, AB .
AMERICAN HEART JOURNAL, 2000, 140 (03) :379-384
[5]  
Dempfle Carl-Erik, 2005, Semin Vasc Med, V5, P315, DOI 10.1055/s-2005-922476
[6]  
Derhaschnig U, 2002, CLIN CHEM, V48, P1924
[7]   The exciting story of cardiac biomarkers: From retrospective detection to gold diagnostic standard for acute myocardial infarction and more [J].
Dolci, A. ;
Panteghini, M. .
CLINICA CHIMICA ACTA, 2006, 369 (02) :179-187
[8]   10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from Internal Quality Control data [J].
Dolci, Alberto ;
Dominici, Roberto ;
Luraschi, Paola ;
Panteghini, Mauro .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (12) :1495-1496
[9]  
Fareed J, 1998, CLIN CHEM, V44, P1845
[10]   The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction [J].
Lee, LV ;
Ewald, GA ;
McKenzie, CR ;
Eisenberg, PR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) :628-633